se ha leído el artículo
array:23 [ "pii" => "S0210569118300913" "issn" => "02105691" "doi" => "10.1016/j.medin.2018.03.003" "estado" => "S300" "fechaPublicacion" => "2019-03-01" "aid" => "1198" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Intensiva. 2019;43:103-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1054 "formatos" => array:3 [ "EPUB" => 121 "HTML" => 602 "PDF" => 331 ] ] "itemSiguiente" => array:18 [ "pii" => "S0210569118302845" "issn" => "02105691" "doi" => "10.1016/j.medin.2018.09.017" "estado" => "S300" "fechaPublicacion" => "2019-03-01" "aid" => "1285" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2019;43:108-20" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 19353 "formatos" => array:3 [ "EPUB" => 207 "HTML" => 14586 "PDF" => 4560 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ARTÍCULO ESPECIAL</span>" "titulo" => "Empleo de ECMO en UCI. Recomendaciones de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "108" "paginaFinal" => "120" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The use of ECMO in ICU. Recommendations of the Spanish Society of Critical Care Medicine and Coronary Units" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1214 "Ancho" => 2167 "Tamanyo" => 208403 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Esquema propuesto para confirmar la correcta posición del balón para la oclusión aórtica.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "E. Fernández-Mondéjar, M.P. Fuset-Cabanes, T. Grau-Carmona, M. López-Sánchez, Ó. Peñuelas, J.L. Pérez-Vela, J.M. Pérez-Villares, J.J. Rubio-Muñoz, M. Solla-Buceta" "autores" => array:9 [ 0 => array:2 [ "nombre" => "E." "apellidos" => "Fernández-Mondéjar" ] 1 => array:2 [ "nombre" => "M.P." "apellidos" => "Fuset-Cabanes" ] 2 => array:2 [ "nombre" => "T." "apellidos" => "Grau-Carmona" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "López-Sánchez" ] 4 => array:2 [ "nombre" => "Ó." "apellidos" => "Peñuelas" ] 5 => array:2 [ "nombre" => "J.L." "apellidos" => "Pérez-Vela" ] 6 => array:2 [ "nombre" => "J.M." "apellidos" => "Pérez-Villares" ] 7 => array:2 [ "nombre" => "J.J." "apellidos" => "Rubio-Muñoz" ] 8 => array:2 [ "nombre" => "M." "apellidos" => "Solla-Buceta" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173572718302200" "doi" => "10.1016/j.medine.2018.12.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572718302200?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118302845?idApp=WMIE" "url" => "/02105691/0000004300000002/v1_201902210707/S0210569118302845/v1_201902210707/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0210569118300159" "issn" => "02105691" "doi" => "10.1016/j.medin.2018.01.004" "estado" => "S300" "fechaPublicacion" => "2019-03-01" "aid" => "1168" "copyright" => "Elsevier España, S.L.U. y SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Med Intensiva. 2019;43:90-102" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3293 "formatos" => array:3 [ "EPUB" => 167 "HTML" => 2323 "PDF" => 803 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Transporte interhospitalario con membrana de oxigenación extracorpórea: cuestiones a resolver" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "90" "paginaFinal" => "102" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Issues to resolve with the use of extracorporeal membrane oxygenation during interfacility transportation" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3572 "Ancho" => 2382 "Tamanyo" => 913957 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Propuesta de <span class="elsevierStyleItalic">checklist</span> a realizar por el hospital de origen: criterios de activación del equipo ECMO, datos clínicos, analíticos y pruebas de imagen relevantes, necesidades instrumentales y de espacio para colocación del soporte extracorpóreo. BIAC: balón de contrapulsación; ECMO: <span class="elsevierStyleItalic">extracorporeal membrane oxygenation</span>; FMO: fallo multiorgánico; FR: frecuencia respiratoria; iNO: óxido nítrico; PAD: presión arterial diastólica, PAM: presión arterial media; PAS: presión arterial sistólica; PEEP: presión positiva telespiratoria; TC: tomografía computarizada; TCRR: terapias continuas de remplazo renal.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Burgueño, C. González, A. Sarralde, F. Gordo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Burgueño" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "González" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Sarralde" ] 3 => array:2 [ "nombre" => "F." "apellidos" => "Gordo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173572718302194" "doi" => "10.1016/j.medine.2018.12.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572718302194?idApp=WMIE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118300159?idApp=WMIE" "url" => "/02105691/0000004300000002/v1_201902210707/S0210569118300159/v1_201902210707/es/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Point of view</span>" "titulo" => "Is there a role for iron supplementation in critically ill patients?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "103" "paginaFinal" => "107" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Muñoz, S. Gómez-Ramírez" "autores" => array:2 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Muñoz" "email" => array:1 [ 0 => "mmunoz@uma.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "S." "apellidos" => "Gómez-Ramírez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Surgical Specialties, Biochemistry and Immunology, School of Medicine, University of Málaga, Málaga, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Internal Medicine, University Hospital “Virgen de la Victoria”, Málaga, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Suplementos de hierro: ¿son útiles en el paciente crítico?" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 989 "Ancho" => 2334 "Tamanyo" => 189714 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A tentative algorithm for management of iron deficiency in critically ill patients.<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0055" class="elsevierStylePara elsevierViewall">The presence of iron deficiency can be confirmed by reticulocyte content (<28<span class="elsevierStyleHsp" style=""></span>pg), percentage of hypocromic red cells (>5%), or ferritin index >2.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0060" class="elsevierStylePara elsevierViewall">Moderate-to-severe anemia: hemoglobin <11<span class="elsevierStyleHsp" style=""></span>g/dL.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0065" class="elsevierStylePara elsevierViewall">Low dose (30–60<span class="elsevierStyleHsp" style=""></span>mg/day) of newer oral iron formulations, such as sucrosomial iron, could be preferred. Switch to intravenous iron if intolerance to or lack of efficacy of oral iron.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0070" class="elsevierStylePara elsevierViewall">Iron sucrose (100<span class="elsevierStyleHsp" style=""></span>mg/48<span class="elsevierStyleHsp" style=""></span>h) or ferric carboxymaltose/iron isomaltoside/low molecular weight iron dextran (500<span class="elsevierStyleHsp" style=""></span>mg/week). IVI administration should be discontinued if there is evidence of iron overload, as indicated by serum ferritin ≥1000<span class="elsevierStyleHsp" style=""></span>ng/mL or transferrin saturation ≥50%.</p></li></ul></p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Anemia is the most common hematological disorder among patients admitted to the intensive care unit (ICU). The majority of critically ill patients presented with anemia upon ICU admission (up to 30% with hemoglobin <10<span class="elsevierStyleHsp" style=""></span>g/dL), which tends to persist throughout the duration of their ICU stay and for many weeks after ICU discharge, unless modified by red blood cell transfusions (RBCT).<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">1</span></a> Though the etiology of anemia of critically ill patients is multifactorial and complex, iron restricted erythropoiesis, due to absolute iron deficiency or hepcidin-induced iron sequestration with decreased iron availability (functional iron deficiency), is commonly involved in its induction and persistence.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The most important consequence of anemia is a decreased oxygen delivery to tissues. While mild anemia does not seem to adversely affect patient's outcome, severe anemia may result in a 50% increase in the odds ratio of mortality, though RBCTs also result in a dose-dependent increase of mortality risk (up to 4-fold when more than 4 RBCT units are administered).<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">2</span></a> Even when used with restrictive criteria, patients receiving RBCT have poorer clinical outcomes.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">3</span></a> Therefore, severe anemia should be avoided, corrected or, at least, ameliorated before oxygen delivery and consumption are impaired, and RBCT needed.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Additionally, non-anemic patients with reduced or absent iron stores may have symptoms such as fatigue or reduced exercise tolerance, as recently reported for patients discharged after prolonged ICU stay.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">4</span></a> In congestive heart failure, iron deficiency was also independently associated with compromised physical performance and quality of life, and an increase of cardiovascular and all-cause mortality; in contrast, treatment of iron deficiency with intravenous iron have been shown to improve short- and long-term functional status.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">To avoid the development and/or progression of anemia in non-bleeding ICU patients, reduction of blood losses (reduction in diagnostic phlebotomy frequency and volume, use of in-line closed blood conservation devices, cell salvage during surgical procedures, etc.) and pharmacologic stimulation of erythropoiesis should be attempted. The administration of erythropoietin emerged as a promising therapeutic option. However, when a restrictive transfusion protocol was in place, a reduction in RBCT was not consistently demonstrated, except for one randomized trial in which adjuvant intravenous iron was associated with erythropoietin.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">1</span></a> Failure of erythropoietin treatment in reducing RBCT may have been related to inadequate iron supplementation. Thus, laboratory definitions for absolute and functional iron deficiency, as well as doses and routes of iron supplementation should deserve especial attention.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Accurate diagnosis of iron restricted erythropoiesis is essential before initiating iron supplementation. However, diagnosis of iron deficiency at ICU is difficult as ferritin levels may be elevated as part of the inflammatory response in ICU patients. A ferritin <100<span class="elsevierStyleHsp" style=""></span>ng/dL indicates insufficient iron stores to support erythropoiesis in the setting of anemia and inflammation (e.g., C-reactive protein >5<span class="elsevierStyleHsp" style=""></span>mg/L) which is common among ICU patients. Further markers for absolute iron deficiency are transferrin saturation <20% with ferritin concentrations of 100–300<span class="elsevierStyleHsp" style=""></span>ng/mL, reticulocyte hemoglobin content <28<span class="elsevierStyleHsp" style=""></span>pg, hypochromic red cells >5% or ferritin index >2<span class="elsevierStyleSup">6</span> (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). The ferritin index is the ratio between the serum-soluble transferrin receptor and the logarithm of serum ferritin.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">6</span></a> Ferritin concentrations >300<span class="elsevierStyleHsp" style=""></span>ng/mL with transferrin saturation <20% are indicative of functional iron deficiency. These values and parameters may signal the need for intervention, as parameters of the iron status, but not anemia per se, independently influence transfusion rate, complications and in-hospital mortality<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">7</span></a> (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">High dose oral ferrous sulfate (325<span class="elsevierStyleHsp" style=""></span>mg thrice daily; approx. 300<span class="elsevierStyleHsp" style=""></span>mg elemental iron/day) has been shown to reduce RBCT requirements in critically ill patients with iron deficiency, though there was not a formal transfusion protocol.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">8</span></a> Recent evidence from the IRONOUT study in patients with chronic heart failure further supports the ineffectiveness of oral iron in the setting of inflammation.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">9</span></a> However, oral sucrosomial iron has an absorption mechanism which is mostly hepcidin-independent, and its administration at low doses (30–60<span class="elsevierStyleHsp" style=""></span>mg) has been shown effective in clinical settings (e.g., chronic kidney disease) where intravenous iron seemed to be the only treatment option.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">10</span></a> A possible role of sucrosomial iron needs to be tested in ICU patients.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Some characteristics of available intravenous iron formulations in Spain are depicted in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. The total iron dose (TID) is calculated according to: TID<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>body weight (kg)<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2.4<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>hemoglobin deficiency (target hemoglobin level<span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span>patient hemoglobin level; g/dL)<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>500–1000<span class="elsevierStyleHsp" style=""></span>mg (repletion of iron stores). For the approved indications and at recommended doses, all available “original” intravenous iron formulations are essentially equal in terms of safety and efficacy.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">11</span></a> However, when administering intravenous iron, more stable formulations with low labile iron content (e.g., ferric carboxymaltose or iron isomaltoside) could be preferred to avoid oxidative stress,<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">11</span></a> though drug acquisition costs are considerably higher. Maximal single dose will depend on the available compound, but we suggested lower single dosing schedules (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Iron status should be checked weekly, and intravenous iron administration discontinued if there is evidence of iron overload, as indicated by serum ferritin ≥1000<span class="elsevierStyleHsp" style=""></span>ng/mL or transferrin saturation ≥50%. In patients receiving ferric carboxymaltose, phosphate levels should be periodically monitored for early detection and management of hypophosphatemia.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">11</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">The analysis of 6 randomized trials on iron supplementation in adult critical care with 860 patients found no difference in RBCT or hemoglobin, except in two trials (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). These two trials involved the administration of iron isomaltoside IV to non-anemic patients at the end of cardiac surgery or oral iron to critically ill surgical patients with iron deficiency on admission. There was also no difference in secondary outcomes of mortality, in-hospital infection, or length of stay (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). However, there was considerable heterogeneity between trials in study design, populations, interventions, and outcomes, and administered intravenous iron doses may have been insufficient to meet patents’ needs (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In addition, doses were substantially lower than in the REPAIR-IDA trial of intravenous iron to treat iron-deficiency anemia in non-dialysis-dependent chronic kidney disease (ferric carboxymaltose 1500<span class="elsevierStyleHsp" style=""></span>mg vs. iron sucrose 1000<span class="elsevierStyleHsp" style=""></span>mg), where clinically significant increments on hemoglobin levels were observed.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">12</span></a></p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">Thus, more well-designed trials are required to ascertain which ICU patients are more likely to benefit from these treatments in terms of patient-focused outcomes, as well as to identify the optimal doses and administration schedules. Meanwhile, because of the absence of definitive clinical data, it seems reasonable to limit total intravenous iron dose to 2000<span class="elsevierStyleHsp" style=""></span>mg, and to avoid its administration in patients with hyperferritinemia (>800<span class="elsevierStyleHsp" style=""></span>ng/mL) or in the setting of acute infection, especially in sepsis.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">11</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflict of interests</span><p id="par0050" class="elsevierStylePara elsevierViewall">Manuel Muñoz has received industry-supplied funding for consultancies, lectures and/or travel from Pharmacosmos, Vifor Pharma, Zambon, Pharmanutra, Sandoz and Celgene, and is member of the editorial board of Revista Española de Anestesiología y Reanimación and Blood Transfusion. Susana Gómez-Ramirez has nothing to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-03-13" "fechaAceptado" => "2018-03-17" "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 989 "Ancho" => 2334 "Tamanyo" => 189714 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A tentative algorithm for management of iron deficiency in critically ill patients.<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0055" class="elsevierStylePara elsevierViewall">The presence of iron deficiency can be confirmed by reticulocyte content (<28<span class="elsevierStyleHsp" style=""></span>pg), percentage of hypocromic red cells (>5%), or ferritin index >2.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0060" class="elsevierStylePara elsevierViewall">Moderate-to-severe anemia: hemoglobin <11<span class="elsevierStyleHsp" style=""></span>g/dL.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0065" class="elsevierStylePara elsevierViewall">Low dose (30–60<span class="elsevierStyleHsp" style=""></span>mg/day) of newer oral iron formulations, such as sucrosomial iron, could be preferred. Switch to intravenous iron if intolerance to or lack of efficacy of oral iron.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0070" class="elsevierStylePara elsevierViewall">Iron sucrose (100<span class="elsevierStyleHsp" style=""></span>mg/48<span class="elsevierStyleHsp" style=""></span>h) or ferric carboxymaltose/iron isomaltoside/low molecular weight iron dextran (500<span class="elsevierStyleHsp" style=""></span>mg/week). IVI administration should be discontinued if there is evidence of iron overload, as indicated by serum ferritin ≥1000<span class="elsevierStyleHsp" style=""></span>ng/mL or transferrin saturation ≥50%.</p></li></ul></p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Iron<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> sucrose \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">LMWID<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Ferric<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a> carboxymaltose \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Iron<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">d</span></a> isomaltoside \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Brand name</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Venofer<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cosmofer<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Injectafer<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Monofer<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ferinject<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Monoferro<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Molecular weight (kD)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30–60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">165 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">150 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">150 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Labile iron (% injected dose)</span><a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">e</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Maximal single dose (mg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">200 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20<span class="elsevierStyleHsp" style=""></span>mg/kg (max 1000<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20<span class="elsevierStyleHsp" style=""></span>mg/kg \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Suggested dosage in ICU patients:</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Dose (mg)/frequency (days) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">100/2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">500/7<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">500/7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">500/7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Infusion time (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Maximal total dose (mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2000 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2000 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2000 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">200 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Product cost per 1000</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">mg (€)</span><a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">g</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">112 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">103 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">192 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">192 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1967099.png" ] ] ] "notaPie" => array:7 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Venofer summary of product characteristics. <a class="elsevierStyleInterRef" target="_blank" id="intr0005" href="http://www.luitpold.com/documents/22.pdf">http://www.luitpold.com/documents/22.pdf</a> (accessed 18.02.18).</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">LMWID, low molecular weight iron dextran; Cosmofer summary of product characteristics. <a class="elsevierStyleInterRef" target="_blank" id="intr0010" href="http://www.cosmofer.com/product/cosmofer-spc/cosmofer-spc.aspx">http://www.cosmofer.com/product/cosmofer-spc/cosmofer-spc.aspx</a> (accessed 18.02.18).</p>" ] 2 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Ferinject summary of product characteristics. <a class="elsevierStyleInterRef" target="_blank" id="intr0015" href="http://www.ferinject.co.uk/smpc/">http://www.ferinject.co.uk/smpc/</a> (accessed 18.02.18).</p>" ] 3 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "d" "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Monofer summary of product characteristics. <a class="elsevierStyleInterRef" target="_blank" id="intr0020" href="http://www.monofer.com/spc.aspx">http://www.monofer.com/spc.aspx</a> (accessed 18.02.18).</p>" ] 4 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "e" "nota" => "<p class="elsevierStyleNotepara" id="npar0025">Jahn MR, et al. Eur J Pharm Biopharm 2011; 78:480–91.</p>" ] 5 => array:3 [ "identificador" => "tblfn0030" "etiqueta" => "f" "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Although it is not an approved dosing by European Medicines Agency, Auerbach et al. (Am J Hematol 2011; 86: 860) have not observed any serious adverse events in over 5000 administration of LMWID at doses of 1000<span class="elsevierStyleHsp" style=""></span>mg in 250<span class="elsevierStyleHsp" style=""></span>mL of normal saline over 1<span class="elsevierStyleHsp" style=""></span>h.</p>" ] 6 => array:3 [ "identificador" => "tblfn0035" "etiqueta" => "g" "nota" => "<p class="elsevierStyleNotepara" id="npar0035">Quintana M, et al. Blood Transfus 2017; 15:438–46.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Characteristics of different intravenous iron formulations available in Spain.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">CPB, cardio-pulmonary bypass; EPO, recombinant erythropoietin; FCM, ferric carboxymaltose; FS, ferrous sulphate; Hb, hemoglobin; ICU, Intensive Care Unit; IS, iron sucrose; ISM iron isomaltoside-1000; IVI, intravenous iron; LOS, length of hospital stay; OBS, observational study; RBCT, red blood cell transfusion.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Study reference setting \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Baseline Hb (g/dL) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Iron compound dose (mg) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">RBCT (% or units) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Infection (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Mortality (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hospital stay (days) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Madi-Jebara et al.<a class="elsevierStyleCrossRef" href="#tblfn0040"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS:40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS (437<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">25% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">J Cardiothorac Vas Anesth 2004;18:59–63. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS+EPO: 40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS (402<span class="elsevierStyleHsp" style=""></span>mg)<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>EPO(300 U<span class="elsevierStyleHsp" style=""></span>kg<span class="elsevierStyleSup">−1</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">17% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiac surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo: 40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Karkouti et al.<a class="elsevierStyleCrossRef" href="#tblfn0045"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS:11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS (600<span class="elsevierStyleHsp" style=""></span>mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Can J Anaesth 2006; 53:11–9. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS+EPO: 10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS (600<span class="elsevierStyleHsp" style=""></span>mg)<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>EPO (900 U<span class="elsevierStyleHsp" style=""></span>kg<span class="elsevierStyleSup">−1</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiac & orthopedic surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo: 10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">All with oral iron after discharge \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Garrido-Martín et al. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS:54 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS (300<span class="elsevierStyleHsp" style=""></span>mg preop<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>300<span class="elsevierStyleHsp" style=""></span>mg postop)<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>oral after discharge \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">37% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Interact Cardiovasc Thorac Surg 2012; 15:1013–8. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">105<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>day<span class="elsevierStyleSup">−1</span> preop, postop and after discharge \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiac surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Oral iron:53 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">105<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>day<span class="elsevierStyleSup">−1</span> after discharge \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">51% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo: 52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">? \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pieracci et al.<a class="elsevierStyleCrossRef" href="#tblfn0050"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">IS: 75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">100<span class="elsevierStyleHsp" style=""></span>mg IV thrice weekly up to 2 weeks \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">73.3% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">58.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">14 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Crit Care Med 2014;42:2048–57. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trauma ICU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo: 75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">62.7% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">69.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Johanson et al.<a class="elsevierStyleCrossRef" href="#tblfn0055"><span class="elsevierStyleSup">d</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">ISM:30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">ISM (1000<span class="elsevierStyleHsp" style=""></span>mg at CPB end or wound closure) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.3% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vox Sanguinis 2015; 109:257–66. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cardiac surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo:30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20.0% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Litton et al.<span class="elsevierStyleSup">e</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FCM: 70 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FCM 500<span class="elsevierStyleHsp" style=""></span>mg/infusion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">54% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">28.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Intensive Care Med 2016; 42:1715–22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Up to 2000<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">79 units \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Medical and surgical ICU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Placebo: 70 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">56% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">18 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">121 units \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1967100.png" ] ] ] "notaPie" => array:4 [ 0 => array:3 [ "identificador" => "tblfn0040" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0040">Randomization bias Hb levels: in the control group Hb were significantly higher than these observed in the treated groups.</p>" ] 1 => array:3 [ "identificador" => "tblfn0045" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0045">It was estimated a priori that 20 patients in each group would be sufficient to detect an incremental increase in Hb of 0.8<span class="elsevierStyleHsp" style=""></span>g/dL. A total of 3473 patients were screened. Of the 140 eligible patients, 102 refused to participate and 38 were randomized, and primary outcome was available in 31.</p>" ] 2 => array:3 [ "identificador" => "tblfn0050" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0050">In subgroup analysis, also no benefit was observed for those receiving all 6 doses of iron sucrose or placebo. Follow-up 42 days or discharge.</p>" ] 3 => array:3 [ "identificador" => "tblfn0055" "etiqueta" => "d" "nota" => "<p class="elsevierStyleNotepara" id="npar0055">Hb levels at postop day 5. One month after surgery, significantly more patients were non-anemic in the intravenous iron isomaltoside 1000-treated group compared to the placebo group (38.5% vs. 8.0%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0019).</p> <p class="elsevierStyleNotepara" id="npar0060"><span class="elsevierStyleSup">e</span>70% surgical patients. Inclusion criteria Hb <10<span class="elsevierStyleHsp" style=""></span>g/dL, ferritin <1200<span class="elsevierStyleHsp" style=""></span>ng/mL, transferrin saturation <50%. Most patients received a total of 500<span class="elsevierStyleHsp" style=""></span>mg FCM. Only 15 patients received 2 doses, and only 2 patients received 3 doses.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Randomized controlled trials evaluating the effect of iron administration in ICU patients (6 studies, 660 patients).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib0065" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anemia and red blood cell transfusion: advances in critical care" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.M. Napolitano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Crit Care Clin" "fecha" => "2017" "volumen" => "33" "paginaInicial" => "345" "paginaFinal" => "364" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0070" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The CRIT study: anaemia and blood transfusion in the critically ill – current clinical practice in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.L. Corwin" 1 => "A. Gettinger" 2 => "R.G. Pearl" 3 => "M.P. Fink" 4 => "M.M. Levy" 5 => "E. Abraham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.CCM.0000104112.34142.79" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2004" "volumen" => "32" "paginaInicial" => "39" "paginaFinal" => "52" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14707558" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0075" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.R. Leal-Noval" 1 => "M. Muñoz-Gómez" 2 => "M. Jiménez-Sánchez" 3 => "A. Cayuela" 4 => "M. Leal-Romero" 5 => "A. Puppo-Moreno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2013" "volumen" => "39" "paginaInicial" => "445" "paginaFinal" => "453" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0080" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "AtlanREA group" "etal" => true "autores" => array:6 [ 0 => "S. Lasocki" 1 => "N. Chudeau" 2 => "T. Papet" 3 => "D. Tartiere" 4 => "A. Roquilly" 5 => "L. Carlier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13054-014-0542-9" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2014" "volumen" => "18" "paginaInicial" => "542" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25529060" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0085" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of anemia in patients with congestive heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.T. Goodnough" 1 => "J. Comin-Colet" 2 => "S. Leal-Noval" 3 => "S. Ozawa" 4 => "J. Takere" 5 => "D. Henry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ajh.24595" "Revista" => array:6 [ "tituloSerie" => "Am J Hematol" "fecha" => "2017" "volumen" => "92" "paginaInicial" => "88" "paginaFinal" => "93" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27779769" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0090" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Forum for debate: safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Muñoz Gómez" 1 => "E. Bisbe Vives" 2 => "M. Basora Macaya" 3 => "J.A. García Erce" 4 => "A. Gómez Luque" 5 => "S.R. Leal-Noval" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Intensiva" "fecha" => "2015" "volumen" => "39" "paginaInicial" => "552" "paginaFinal" => "562" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0095" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Uscinska" 1 => "B. Sobkowicz" 2 => "R. Sawicki" 3 => "I. Kiluk" 4 => "M. Baranicz" 5 => "T. Stepek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11739-014-1170-8" "Revista" => array:6 [ "tituloSerie" => "Intern Emerg Med" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "337" "paginaFinal" => "344" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25502592" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0100" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F.M. Pieracci" 1 => "P. Henderson" 2 => "J.R. Rodney" 3 => "D.N. Holena" 4 => "A. Genisca" 5 => "I. Ip" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Surg Infect (Larchmt)" "fecha" => "2009" "volumen" => "10" "paginaInicial" => "9" "paginaFinal" => "19" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0105" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.D. Lewis" 1 => "R. Malhotra" 2 => "A.F. Hernandez" 3 => "S.E. McNulty" 4 => "A. Smith" 5 => "G.M. Felker" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "JAMA" "fecha" => "2017" "volumen" => "317" "paginaInicial" => "1958" "paginaFinal" => "1966" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0110" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Pisani" 1 => "E. Riccio" 2 => "M. Sabbatini" 3 => "M. Andreucci" 4 => "A. Del Rio" 5 => "B. Visciano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfu357" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2015" "volumen" => "30" "paginaInicial" => "645" "paginaFinal" => "652" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25395392" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0115" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The safety of available treatment options for iron-deficiency anemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Muñoz" 1 => "S. Gómez-Ramírez" 2 => "S. Bhandari" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Opin Drug Saf" "fecha" => "2018" "volumen" => "17" "paginaInicial" => "149" "paginaFinal" => "159" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0120" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.E. Onken" 1 => "D.B. Bregman" 2 => "R.A. Harrington" 3 => "D. Morris" 4 => "J. Buerkert" 5 => "D. Hamerski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gft251" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2014" "volumen" => "29" "paginaInicial" => "833" "paginaFinal" => "842" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23963731" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02105691/0000004300000002/v1_201902210707/S0210569118300913/v1_201902210707/en/main.assets" "Apartado" => array:4 [ "identificador" => "437" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Punto de vista" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02105691/0000004300000002/v1_201902210707/S0210569118300913/v1_201902210707/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210569118300913?idApp=WMIE" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 11 | 8 | 19 |
2024 Octubre | 76 | 78 | 154 |
2024 Septiembre | 67 | 47 | 114 |
2024 Agosto | 79 | 58 | 137 |
2024 Julio | 102 | 43 | 145 |
2024 Junio | 140 | 42 | 182 |
2024 Mayo | 94 | 41 | 135 |
2024 Abril | 90 | 43 | 133 |
2024 Marzo | 85 | 48 | 133 |
2024 Febrero | 88 | 42 | 130 |
2024 Enero | 59 | 50 | 109 |
2023 Diciembre | 47 | 43 | 90 |
2023 Noviembre | 54 | 43 | 97 |
2023 Octubre | 60 | 37 | 97 |
2023 Septiembre | 60 | 42 | 102 |
2023 Agosto | 48 | 19 | 67 |
2023 Julio | 53 | 32 | 85 |
2023 Junio | 66 | 18 | 84 |
2023 Mayo | 80 | 47 | 127 |
2023 Abril | 84 | 30 | 114 |
2023 Marzo | 163 | 47 | 210 |
2023 Febrero | 120 | 34 | 154 |
2023 Enero | 118 | 37 | 155 |
2022 Diciembre | 125 | 47 | 172 |
2022 Noviembre | 129 | 56 | 185 |
2022 Octubre | 125 | 60 | 185 |
2022 Septiembre | 119 | 76 | 195 |
2022 Agosto | 104 | 62 | 166 |
2022 Julio | 115 | 66 | 181 |
2022 Junio | 116 | 58 | 174 |
2022 Mayo | 99 | 63 | 162 |
2022 Abril | 152 | 72 | 224 |
2022 Marzo | 125 | 70 | 195 |
2022 Febrero | 99 | 56 | 155 |
2022 Enero | 138 | 59 | 197 |
2021 Diciembre | 104 | 66 | 170 |
2021 Noviembre | 110 | 54 | 164 |
2021 Octubre | 123 | 92 | 215 |
2021 Septiembre | 89 | 53 | 142 |
2021 Agosto | 81 | 44 | 125 |
2021 Julio | 60 | 55 | 115 |
2021 Junio | 70 | 59 | 129 |
2021 Mayo | 128 | 77 | 205 |
2021 Abril | 269 | 96 | 365 |
2021 Marzo | 183 | 60 | 243 |
2021 Febrero | 173 | 48 | 221 |
2021 Enero | 145 | 43 | 188 |
2020 Diciembre | 111 | 28 | 139 |
2020 Noviembre | 134 | 29 | 163 |
2020 Octubre | 124 | 54 | 178 |
2020 Septiembre | 70 | 49 | 119 |
2020 Agosto | 99 | 28 | 127 |
2020 Julio | 99 | 44 | 143 |
2020 Junio | 78 | 32 | 110 |
2020 Mayo | 89 | 30 | 119 |
2020 Abril | 89 | 23 | 112 |
2020 Marzo | 60 | 13 | 73 |
2020 Febrero | 158 | 51 | 209 |
2020 Enero | 59 | 26 | 85 |
2019 Diciembre | 69 | 28 | 97 |
2019 Noviembre | 52 | 31 | 83 |
2019 Octubre | 62 | 28 | 90 |
2019 Septiembre | 59 | 32 | 91 |
2019 Agosto | 62 | 40 | 102 |
2019 Julio | 62 | 38 | 100 |
2019 Junio | 32 | 21 | 53 |
2019 Mayo | 7 | 10 | 17 |
2019 Abril | 0 | 7 | 7 |
2019 Marzo | 24 | 28 | 52 |
2019 Febrero | 4 | 9 | 13 |
2019 Enero | 0 | 2 | 2 |
2018 Octubre | 2 | 2 | 4 |
2018 Abril | 1 | 3 | 4 |